MetaVia (MTVA) Return on Capital Employed Growth (1y) (2017 - 2026)
MetaVia (MTVA) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -785.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,629.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3,193.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -28.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 399.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -310.00 |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | 4,955.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,955.00 |
| Dec 31, 2025 | 7,565.00 |
| Sep 30, 2025 | -11,264.00 |
| Jun 30, 2025 | -20,644.00 |
| Mar 31, 2025 | -36,587.00 |
| Dec 31, 2024 | -26,429.00 |
| Sep 30, 2024 | -2,258.00 |
| Jun 30, 2024 | -3,930.00 |
| Mar 31, 2024 | 5,724.00 |
| Dec 31, 2023 | 22,469.00 |
| Sep 30, 2023 | 11,543.00 |
| Jun 30, 2023 | 7,034.00 |
| Mar 31, 2023 | 1,899.00 |
| Dec 31, 2022 | -7,568.00 |
| Sep 30, 2022 | 21,138.00 |
| Jun 30, 2022 | 13,033.00 |
| Mar 31, 2022 | 13,430.00 |
| Dec 31, 2021 | 20,476.00 |
| Sep 30, 2021 | -18,452.00 |
| Jun 30, 2021 | -4,599.00 |